[3H]MRS 1754, a selective antagonist radioligand for A2B adenosine receptors

被引:81
|
作者
Ji, XD
Kim, YC
Ahern, DG
Linden, J
Jacobson, KA
机构
[1] NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[2] NEN Life Sci Prod, Boston, MA 02118 USA
[3] Univ Virginia, Hlth Sci Ctr, Dept Internal Med & Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA
关键词
G protein-coupled receptors; tritium purines; xanthines; adenosine analogues;
D O I
10.1016/S0006-2952(01)00531-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
MRS 1754 [N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy]acetamide] is a selective antagonist ligand of A(2B) adenosine receptors. This is the least well-defined adenosine receptor subtype, and A(2B) antagonists have potential as antiasthmatic drugs. For use as a radioligand, MRS 1754, a p-cyanoanilide xanthine derivative, was tritiated on the propyl groups in a two-step reaction using a p-carboxamido precursor, which was dehydrated to the cyano species using trifluoroacetic anhydride. [H-3]MRS 1754 (150 Ci/mmol) bound to recombinant human A(2B) adenosine receptors in membranes of stably transfected HEK-293 cells. Specific binding was saturable, competitive, and followed a one-site model, with a K-D value of 1.13 +/- 0.12 nM and a B-max value of 10.9 +/- 0.6 pmol/mg protein. Specific binding utilizing 0.7 nM [H-3]MRS 1754 was > 70% of total binding. The affinity calculated from association and dissociation binding constants was 1.22 nM (N = 4). Binding to membranes expressing rat and human A(1) and A(3), adenosine receptors was not significant, and binding in membranes of HEK-293 cells expressing human A(2A) receptors was of low affinity (K-D > 50 nM). The effects of cations and chelators were explored. Specific binding was constant over a pH range of 4.5 to 6.5, with reduced binding at higher pH. The pharmacological profile in competition experiments with [H-3]MRS 1754 was consistent with the structure-activity relationship for agonists and antagonists at A(2B) receptors. The K-i values of XAC (xanthine amine congener) and CPX (8-cyclopentyl-1,3-diproplylxanthine) were 16 and 55 nM, respectively. NECA (5'-N-ethylcarboxamidoadenosine) competed for [H-3]MRS 1754 binding with a K-i of 570 nM, similar to its potency in functional assays. Thus, [H-3]MRS 1754 is suitable as a selective, high-affinity radioligand for A(2B) receptors. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:657 / 663
页数:7
相关论文
共 50 条
  • [31] Heteromerization of adenosine A2A and A2B receptors
    Hinz, Sonja
    Seibt, Benjamin F.
    Schiedel, Anke C.
    Franco, Rafael
    Mueller, Christa E.
    PURINERGIC SIGNALLING, 2014, 10 (04) : 756 - 756
  • [32] Pharmacological profile of the adenosine antagonist, BG9928 at adenosine A2B receptors from different species
    Jin, X.
    Wang, J.
    Kiesman, W.
    Ticho, B.
    Whalley, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 72 - 72
  • [33] The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma
    Zablocki, J
    Kalla, R
    Perry, T
    Palle, V
    Varkhedkar, V
    Xiao, DM
    Piscopio, A
    Maa, T
    Gimbel, A
    Hao, J
    Chu, N
    Leung, K
    Zeng, DW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 609 - 612
  • [34] A2B adenosine receptors promote tumor growth
    Ryzhov, Sergey
    Novitskiy, Sergey V.
    Zaynagetdinov, Rinat
    Goldstein, Anna E.
    Biaggioni, Italo
    Dikov, Mikhail M.
    Feoktistov, Igor
    FASEB JOURNAL, 2008, 22
  • [35] A2b adenosine receptors in cardioprotection: Timing is everything
    Methner, Carmen
    Krieg, Thomas
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 50 (03) : 582 - 583
  • [36] Proinflammatory effects of native A2B adenosine receptors
    Ryzhov, Sergey
    Zaynagetdinov, Rinat Z.
    Goldstein, Anna
    Feoktistov, Igor
    Biaggioni, Italo
    HYPERTENSION, 2007, 50 (04) : E144 - E144
  • [37] A2b adenosine receptors can change their spots
    Cohen, Michael V.
    Yang, Xiulan
    Downey, James M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (08) : 1595 - 1597
  • [38] Medicinal chemistry and pharmacology of A2B adenosine receptors
    Volpini, R
    Costanzi, S
    Vittori, S
    Cristalli, G
    Klotz, KN
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (04) : 427 - 443
  • [39] The impact of adenosine and A2B receptors on glucose homoeostasis
    Ruesing, D.
    Mueller, C. E.
    Verspohl, E. J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (12) : 1639 - 1645
  • [40] Adenosine receptors and diabetes: Focus on the A2B adenosine receptor subtype
    Merighi, Stefania
    Borea, Pier Andrea
    Gessi, Stefania
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 229 - 236